Back to Melanotan-ii research
melanotan-ii melanocortin agonist preclinical animal n preclinical 2026-04-03 PubMed

Brain Region for Oral Sensation Controls Eating and Body Weight

The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections.

Background

The mesencephalic trigeminal nucleus (Mes5) is a brain region primarily known for processing oral sensory-motor information, which is crucial for functions like chewing and swallowing. However, its specific involvement in regulating energy balance, including food intake and body weight, has remained largely unexplored. This study aimed to investigate the role of Mes5 in energy balance and identify potential neural pathways involved in appetite control.

Results

The study confirmed that the Mes5 indeed expresses the melanocortin-4 receptor (MC4R). Microinjection of melanotan-II (MTII) into the Mes5 significantly suppressed food intake by a considerable margin and led to a noticeable reduction in body weight in mice. Chemogenetic activation of NTS POMC-projecting neurons that project to the Mes5 also resulted in a robust suppression of food intake, demonstrating a direct neural circuit influence. While Mes5 MC4Rs were shown to be sufficient for these suppressive effects, they did not appear to be necessary for the baseline control of food intake or body weight. These findings highlight the Mes5 as a novel and functionally relevant target for the melanocortinergic control of food intake and body weight regulation.

Why It Matters

This research identifies a previously unrecognized brain circuit involving the Mes5 and NTS POMC neurons that plays a crucial role in regulating appetite and body weight. Understanding this pathway could open new avenues for developing targeted therapies for obesity and eating disorders. The ability to modulate food intake and body weight by targeting this specific circuit suggests its potential as a novel therapeutic strategy. Future research could explore specific compounds or interventions that selectively activate this Mes5-POMC pathway, potentially leading to new treatments for metabolic conditions. Further studies are needed to elucidate the endogenous role of this circuit and its translational potential in human trials.


melanotan-ii melanocortin agonist mc4r
Source: pubmed:34068091 · Ingested 2026-04-03 · Digest: gemini-2.5-flash